Who are Hyperosmolar sodium lactate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Hypertonic saline 3% bolus administration, Hypertonic Saline 3%, Saline Solution, Hypertonic, NaCl 7.5%, Mannitol (Aridol), Saline solution, 0.6%.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hyperosmolar-sodium-lactate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-19 · How we verify

Hyperosmolar sodium lactate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hyperosmolar sodium lactate (Hyperosmolar sodium lactate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent. Area: Neurology.

phase 3 Osmotic agent Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Hyperosmolar sodium lactate (Hyperosmolar sodium lactate) — Innogene Kalbiotech Pte. Ltd. Hyperosmolar sodium lactate increases serum osmolality to draw fluid from intracellular and interstitial spaces into the intravascular compartment, reducing intracranial pressure and improving cerebral perfusion.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Hyperosmolar sodium lactate TARGET	Hyperosmolar sodium lactate	Innogene Kalbiotech Pte. Ltd	phase 3	Osmotic agent
Hypertonic saline 3% bolus administration	Hypertonic saline 3% bolus administration	Université de Sherbrooke	marketed	Osmotic agent
Hypertonic Saline 3%	Hypertonic Saline 3%	Hospital General Naval de Alta Especialidad - Escuela Medico Naval	marketed	Osmotic agent / Hypertonic solution
Saline Solution, Hypertonic	Saline Solution, Hypertonic	Medical University of Silesia	marketed	Osmotic agent
NaCl 7.5%	NaCl 7.5%	Aristotle University Of Thessaloniki	marketed	Osmotic agent / Electrolyte solution
Mannitol (Aridol)	Mannitol (Aridol)	University of Saskatchewan	marketed	Osmotic agent / Diagnostic bronchial challenge agent
Saline solution, 0.6%	Saline solution, 0.6%	Novaliq GmbH	marketed	Osmotic agent / Ophthalmic decongestant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent class)

Arbor Pharmaceuticals, Inc. · 1 drug in this class
Innogene Kalbiotech Pte. Ltd · 1 drug in this class
Medical University of Silesia · 1 drug in this class
Seref istek · 1 drug in this class
The Hospital for Sick Children · 1 drug in this class
Université de Sherbrooke · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hyperosmolar sodium lactate — Competitive Intelligence Brief. https://druglandscape.com/ci/hyperosmolar-sodium-lactate. Accessed 2026-05-19.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab